Microneedling improves minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes
J Biol Regul Homeost Agents
.
2020 Mar-Apr;34(2):659-661.
doi: 10.23812/19-385-L-51.
Authors
A Sharma
1
,
R Surve
1
,
R Dhurat
1
,
R Sinclair
2
,
T Tan
3
,
Y Zou
3
,
P Müller Ramos
4
,
C Wambier
5
,
I Verner
6
,
M Kovacevic
7
,
A Goren
8
Affiliations
1
Department of Dermatology, LTM Medical College & Hospital Sion, Mumbai, India.
2
Department of Medicine, University of Melbourne, Parkville. VIC, Australia.
3
Skin & Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China.
4
Departamento de Dermatologia e Radioterapia, UNESP, Botucatu, SP, Brazil.
5
Department of Dermatology, Brown University, Rhode Island, USA.
6
Verner Clinic for Dermatology and Aesthetics, Tel Aviv, Israel.
7
Department of Dermatovenereology, Sestre Milosrdnice University Hospital Centre, Zagreb, Croatia.
8
Department of Dermatology, Hairmore Hospital Beijing, Beijing, China.
PMID:
32492993
DOI:
10.23812/19-385-L-51
No abstract available
Keywords:
alopecia; microneedling; minoxidil.
Publication types
Letter
MeSH terms
Administration, Topical
Alopecia*
Humans
Minoxidil
Sulfotransferases
Substances
Minoxidil
Sulfotransferases